Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2011
DOI: 10.1002/anie.201008053
|View full text |Cite
|
Sign up to set email alerts
|

Self‐Assembly of a Bifunctional DNA Carrier for Drug Delivery

Abstract: NIH; National Key Scientific Program of China[2011CB911000]; China National Grand Program on Key Infectious Disease[2009ZX10004-312]; China National Scientific Foundation of China[20805038, 20620130427]; National Basic Research Program of China[2007CB935603, 2010CB732402

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
51
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 82 publications
(52 citation statements)
references
References 34 publications
1
51
0
Order By: Relevance
“…In the present study, we aimed to exploit beneficial characteristics of a DNA‐AuNP hybrid to design a dynamic nanomachine for combined anti‐cancer therapy. First, by taking advantage of DNA as a cargo loading vehicle, we used a G‐quadruplex structure, which is known to interact with several photosensitizers . Second, the pH‐responsive i‐motif DNA structure, which is formed under acidic condition, was used as a pH‐responsive drug delivery carrier .…”
Section: Introductionmentioning
confidence: 99%
“…In the present study, we aimed to exploit beneficial characteristics of a DNA‐AuNP hybrid to design a dynamic nanomachine for combined anti‐cancer therapy. First, by taking advantage of DNA as a cargo loading vehicle, we used a G‐quadruplex structure, which is known to interact with several photosensitizers . Second, the pH‐responsive i‐motif DNA structure, which is formed under acidic condition, was used as a pH‐responsive drug delivery carrier .…”
Section: Introductionmentioning
confidence: 99%
“…[15c] A similar strategy was exploited in the Tan group, but the more cancer cell-specific aptamer sgc8 was used. [20] (Figure 1B). …”
Section: Methods Of Dna-drug Conjugationmentioning
confidence: 99%
“…Reprinted by permission from reference. [20] Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. C) (Top) Synthesis of ApDCs from phosphoramidites A, T, C, G, and the phosphoramidite containing a drug moiety with a photocleavable linker (denoted as phosphoramdite D).…”
Section: Figurementioning
confidence: 99%
“…Recently, aptamer‐derived G‐quadruplex (GQ) has merged as a novel class of cargo molecules to address these challenges. GQ was stabilized by the porphyrin illuminophore containing cationic photosensitizer, such as 5,10,15,20‐tetrakis‐(1‐methyl‐4‐pyridyl)‐21 H ,23 H ‐porphine (TMPyP4) through the intercalation process, which suggested the application of GQ DNA sequence as a carrier for porphyrin type of photosensitizers . Wang et al proposed a method to generate GQ–aptamer–drug platform which takes advantage of the target‐recognition function of DNA aptamer and the TMPyP4‐loading ability of GQ.…”
Section: Biomedical Applicationsmentioning
confidence: 99%
“…Wang et al proposed a method to generate GQ–aptamer–drug platform which takes advantage of the target‐recognition function of DNA aptamer and the TMPyP4‐loading ability of GQ. By doing so, not only the selectivity of G‐quadruplex–aptamer module was achieved, but the CCRF‐CEM cells' toxicity of TMPyP4 delivered by G‐quadruplex–TMPyP4 was doubled compared to TMPyP4 itself . When this conjugate was attached to upconversion nanoparticles, both CCRF‐CEM cancer cells image and therapy were achieved …”
Section: Biomedical Applicationsmentioning
confidence: 99%